NKT cell–dependent PspA-specific IgA production caused by mucosal administration of a novel nanoparticle pneumococcal vaccine
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Tohoku University (20K08836)
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology (17K10013)
- Ministry of Education, Culture, Sports, Science and Technology (24K14742)
This publication has 50 references indexed in Scilit:
- Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcusJournal of Controlled Release, 2024
- Advances in intranasal vaccine delivery: A promising non-invasive route of immunizationVaccine, 2023
- Pneumonia—Overview2021
- Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccineVaccine, 2015
- Pneumococcal PspA and PspC proteins: Potential vaccine candidates for experimental otitis mediaInternational Journal of Pediatric Otorhinolaryngology, 2014
- A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal MeningitisAdvances in Therapy, 2013
- Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA moleculesVaccine, 2000
- Removal of endotoxin from protein solutions by phase separation using triton X-114Journal of Immunological Methods, 1990
- Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes.The EMBO Journal, 1989
- Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgACell, 1986